Final Thoughts on Noom With GLP-1 Medication Noom Med offers a unique blend of psychological support and medical interventions, making it a compelling option for those struggling with weight loss
Tirzepatide (Mounjaro, Zepbound): a dual GIP/GLP-1 receptor agonist
However, the lifestyle intervention guidelines, dating back to 20072008, do not address the need to precisely measure dose, frequency, and type of physical activity or diet and do not suggest ways (e.g., cardiopulmonary exercise testing) other than self-report to monitor intervention compliance or fidelity
In that case, the experienced team can help determine if semaglutide is right for you
Lancet Diabetes & Endocrinology , 7 (11), 834844